All News

Family premiums for employer-sponsored health insurance rose 4% over the past year, averaging $21,342, according to Kaiser Family Foundation (KFF) study findings, with workers contributing $5588 in out-of-pocket costs.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

The White House physician allows the president to attend public events starting Saturday; study details long-term coronavirus disease 2019 symptoms in pregnant women; new poll shows record low approval of the pandemic response.

This week, the top managed care news included President Donald Trump’s discharge from the hospital; a poll finds Americans trust Joe Biden to lead the US health care system; Nobel Prize awarded to scientists who discovered the hepatitis C virus.

Older individuals need medications that focus on effects inside the nervous system, explained John Corboy, MD, of University of Colorado Denver, School of Medicine, and Rocky Mountain MS Center at Anschutz Medical Campus.

Depression affects up to 17% of patients with rheumatoid arthritis, but not all patients are assessed for their mental well-being.

CPAP treatment administered at night was found to lower daytime resting heart rates and reduce the risk of cardiovascular disease (CVD) in patients with prediabetes who have obstructive sleep apnea (OSA).

Antiretroviral therapy (ART) adherence and quality of life were negatively correlated with the occurrence of major depressive disorder in people living with HIV or AIDS.

Just 24.7% of elderly patients with chronic obstructive pulmonary disease (COPD) included in the study demonstrated correct usage of their inhaler.

Researchers found the nucleocapsid protein (NP) antigen of SARS-CoV-2, the virus which causes coronavirus disease 2019 (COVID-19), existed intracellularly in the ocular tissues of a patient who previously had COVID-19.

An editorial criticizes the administration’s response to coronavirus disease 2019 (COVID-19); the National Cancer Institute announces an antibody testing network; 39 states see rises in COVID-19 cases.

Blythe Adamson, PhD, MPH, of Flatiron Health, discusses study results she presented at the annual American Society of Clinical Oncology meeting on the use of immune checkpoint inhibitors in end-of-life care

The future of migraine research will include further investigations into understanding the pathophysiology of migraine outside of CGRP, said Frank Porreca, PhD, professor of pharmacology and anesthesiology at the University of Arizona and a member of the Department of Collaborative Research at Mayo Clinic in Arizona.

Results showed variation by age, gender, and partisan affiliation. But there's agreement on the need to lower the cost of prescription drugs.

Patients hospitalized for acute heart failure during the coronavirus disease 2019 (COVID-19) pandemic had more advanced disease and were more symptomatic, according to study results out of Australia.

In an attempt to develop a multivariable predictive model for days with new-onset migraine headaches, researchers found episodic migraine attacks were not predictable based on self-prediction or on self-reported exposure to common trigger factors.

Research on the long-term use of ozanimod in relapsing forms of multiple sclerosis (MS) has shown the treatment is effective with no new safety concerns.

Migraine prevention helps drive down functional disability among migraineurs, said Peter McAllister, MD, a neurologist, board certified headache specialist, and medical director of the New England Institute for Neurology and Headache.

Two women are awarded the Nobel Prize in Chemistry for CRISPR; Eli Lilly partners with DexCom, Inc; the US arm of AstraZeneca’s coronavirus disease 2019 (COVID-19) vaccine trial remains halted.

More Humana doctors are taking on full global risk under Medicare Advantage than are still using traditional fee-for-service.

Because patients with chronic migraine experience more monthly migraine days (MMD) than those with episodic migraine, chronic migraineurs will experience a greater reduction of MMD with erenumab, said Stephen Silberstein, MD, professor of neurology at Thomas Jefferson University and director of the Headache Center at Jefferson Health.

At a session Tuesday at the Migraine Trust International Symposium, one presentation delved into findings published this year in medication overuse headaches, prevention, and pathophysiology of migraine as well as cluster headaches.

In this episode of Managed Care Cast, we speak with a male patient with breast cancer who was diagnosed with metastatic disease in 2016 about how he lives his life and what he wants people to know about this rare cancer.

In this study from Cape Town, South Africa, patients with comorbid HIV and a history of mental illness had an increased risk of mortality from all causes.

Researchers examine the clinical and pathophysiological mechanisms underlying pain in Parkinson disease.

Racial disparities in insulin pump use among children with type 1 diabetes (T1D) have persisted over the past 15 years, independent of socioeconomic status.

Treatment guidelines for comorbid depression and migraine are warranted to ensure optimal efficacy and avoid possible pitfalls in psychopharmacotherapy, according to study results.

Medication overuse headache is a peculiar disorder where the cure becomes the cause, said Rigmor Jensen, MD, professor of neurology at The University of Copenhagen and director of the Danish Headache Center.